These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9418036)
1. A new simple assay for determining aminoglycoside inactivation in intact cells of Pseudomonas aeruginosa. O'Hara K; Kawabe T; Taniguchi K; Ohnuma M; Nakagawa M; Naitou Y; Sawai T Microbios; 1997; 90(364-365):177-86. PubMed ID: 9418036 [TBL] [Abstract][Full Text] [Related]
3. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones]. Lei YC; Wang HB; Sun ZY; Shen ZY Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918 [TBL] [Abstract][Full Text] [Related]
4. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306 [TBL] [Abstract][Full Text] [Related]
5. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. Gad GF; El-Domany RA; Zaki S; Ashour HM J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321 [TBL] [Abstract][Full Text] [Related]
6. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa. Moriarty F; Elborn S; Tunney M J Microbiol Methods; 2005 May; 61(2):171-9. PubMed ID: 15722142 [TBL] [Abstract][Full Text] [Related]
7. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
8. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa. Islam S; Jalal S; Wretlind B Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880 [TBL] [Abstract][Full Text] [Related]
9. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study. Kim JY; Park YJ; Kwon HJ; Han K; Kang MW; Woo GJ J Antimicrob Chemother; 2008 Sep; 62(3):479-83. PubMed ID: 18606785 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa. Chuanchuen R; Wannaprasat W; Schweizer HP Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):115-22. PubMed ID: 18567450 [TBL] [Abstract][Full Text] [Related]
11. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa. Doi O; Ogura M; Tanaka N; Umezawa H Appl Microbiol; 1968 Sep; 16(9):1276-81. PubMed ID: 4970990 [TBL] [Abstract][Full Text] [Related]
13. Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa. Blahová J; Králiková K; Krcméry V; Mlynarcík D; Trupl J Acta Virol; 1997 Oct; 41(5):293-6. PubMed ID: 9607084 [TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Benveniste R; Davies J Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2276-80. PubMed ID: 4209515 [TBL] [Abstract][Full Text] [Related]
15. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro. Tunney MM; Scott EM J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693 [TBL] [Abstract][Full Text] [Related]
16. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [TBL] [Abstract][Full Text] [Related]
17. 'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa. Tateda K; Ishii Y; Matsumoto T; Yamaguchi K Scand J Infect Dis; 2006; 38(4):268-72. PubMed ID: 16709527 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
19. Surface properties of cells of gentamicin-sensitive and gentamicin-resistant strains of Pseudomonas aeruginosa. Pechey DT; James AM Microbios; 1974; 10A SUPPL(41):111-26. PubMed ID: 4218294 [No Abstract] [Full Text] [Related]
20. Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test. Vedel G J Antimicrob Chemother; 2005 Oct; 56(4):657-64. PubMed ID: 16144872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]